[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
May 10, 1993

Captopril and the Effect of Interferon Gamma on Monocytes

Author Affiliations

Moscow, Russia

Innsbruck, Austria

Arch Intern Med. 1993;153(9):1138-1142. doi:10.1001/archinte.1993.00410090080013

Captopril is used as an antihypertensive drug for its inhibiting effect on angiotensin-converting enzyme, the enzyme that converts inactive angiotensin I to the active vasopressor angiotensin II. Captopril has also been shown to induce immunosuppression by a mechanism that involves monocytes and CD8+ cells. In vivo, captopril was beneficial in patients with rheumatoid arthritis2 and in an animal model of systemic lupus erythematosus.3

To study whether captopril has any direct effects on cells of the monocyte/macrophage lineage, we tested its influence on formation of neopterin, an in vivo marker for immune activation,4 and on tryptophan degradation. Both biochemical pathways are induced by interferon gamma in macrophages.5 We used the human myelomonocytic cell line THP-1 (American Type Culture Collection, Rockville, Md) that behaves similarly in this respect to freshly isolated monocytes.6 Cells grown in RPMI 1640 containing 10% heat-inactivated fetal calf serum, 2 mmol/L of L-glutamine,

First Page Preview View Large
First page PDF preview
First page PDF preview